Clinical Trials Browser

Phase 1/2 × Metastatic Castration-Resistant Prostate Cancer (mCRPC) × Clear all

NCT06126731 2025-11-24

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Phase 1/2 Recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)